Convenience, preference, effectiveness, and safety should be considerations in any treatment decision
Your provider must assess contraindications, baseline kidney function, and medication interactions before recommending any option
In fact, one study showed that people who discontinued Wegovy (another GLP-1) regained 65% of the weight they had lost within less than a year
To view or add a comment, sign in Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech by The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market
And has se several advantages also relating to the risk of overdose and respiratory depression
Log in GLP-1 Probiotic+ Codeage 30 capsules $N/A (MSRP) Already have an account